25+ Years of Evidence

Join the experts’ corner

This page presents publications and webinars from around the globe. It includes evidence for a wide range of treatment sites including malignant and benign disease, different fractionation schedules and motion synchronization techniques for both the CyberKnife® and TomoTherapy® platforms. We update new papers on a regular basis. Please take a moment to explore the page and see the evidence we have collected to truly demonstrate how we are making a change to peoples’ lives.

Featured Content

Pancreatic cancer awareness

Clinical Outcomes And Prognostic Factors Of Stereotactic Body Radiation Therapy Combined With Gemcitabine Plus Capecitabine For Locally Advanced Unresectable Pancreatic Cancer

Date: 2020
Treatment Technique: SBRT
Platform: CyberKnife
Author: Ze-Tian Shen et al.

Adaptive TomoTherapy For Locally Advanced Unresectable Pancreatic Neuroendocrine Tumor: Case Report And Literature Review

Date: 2022
Treatment Technique: IG-IMRT
Platform: TomoTherapy
Author: Kuan-Yi Tu et al.

pancreatic cancer awareness

Use Of Nab-Paclitaxel Plus Gemcitabine Followed By Hypofractionated TomoTherapy With Simultaneous Integrated Boost In Patients With Locally Advanced Pancreatic Cancer

Date: 2022
Treatment Technique: IG-IMRT
Platform: TomoTherapy
Author: Zhan Shi et al.
  • Products

  • Techniques

  • Types

  • Indications

  • Event

  • Formats

Unmatched service to protect uptime and maximize ROI

Industry-leading service to support your ongoing success, from speedy install and optimization, to proactive monitoring and unrivalled on-site service, to smart upgrade paths to keep your system at the leading edge.

Redefining the future of cancer care

Learn how Accuray radiation technologies enable clinicians to get patients back to living their lives, faster. Explore coming innovations that unlock entirely new possibilities.

Treatment Centers

About Accuray

Accuray is expanding radiation therapy: our products can deliver it accurately, precisely and effectively, from oncology to neuro-radiosurgery and beyond.